Purchases and Sales Made in Q2 2022 in Cyteir Therapeutics, Inc. (CYT)
This table provides information about the institutional ownership of Cyteir Therapeutics, Inc. (CYT) during Q2 2022. The information is specifically focused on institutions that hold shares of Cyteir Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 15, 2022
Q2 2022
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-41.8KClosed |
$67.8K - $184K
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
State Street Corp
Boston, MA |
SELL
|
- |
-113K- 82.53% |
$183K - $496K
|
23.9K
$71.8K
|
|
|
Aug 12, 2022
Q2 2022
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-125K- 90.47% |
$203K - $550K
|
13.2K
$39.7K
|
|
|
Aug 12, 2022
Q2 2022
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-149K- 65.71% |
$241K - $654K
|
77.6K
$234K
|
|
|
Aug 12, 2022
Q2 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-463K- 69.69% |
$750K - $2.04M
|
202K
$607K
|
|
|
Aug 15, 2022
Q2 2022
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-1.72MClosed |
$2.79M - $7.57M
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Ra Capital Management, L.P.
Boston, MA |
SELL
|
- |
-3.35MClosed |
$5.43M - $14.7M
|
0
$0
|